Real-World Effectiveness and Safety of Tildrakizumab in a Large Spanish Multicenter Cohort from Spanish Psoriasis Group (GPS)

Thumbnail Image
pharmacy-14-00063-with-cover.pdf (1.65 MB)
Identifiers
URI: https://hdl.handle.net/10641/8237
ISSN: 2226-4787
DOI: 10.3390/pharmacy14030063

Publication date

2026-04-24

Start date of the public exhibition period

End date of the public exhibition period

Authors

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics
Google Scholar
Share
Export

Research Projects

Organizational Units

Journal Issue

Doctoral program

Description

Keywords

Biological therapy, Elderly, Psoriasis, Real-world evidence, Tildrakizumab, Journal Article, Yes

Citation

Llamas-Velasco, M, Hospital, M, Lopez-Ferrer, A, Herranz, P, Ruiz-Villaverde, R, Mateu, A, Garcia-Latasa, F J, Rivera, R, Fernandez-Freire, L R, Alcazar, E D, Santos, S, Arias, S, Gonzalez-Cantero, A, Belinchon, I, Carretero, G, Ferran, M, Ruiz-Genao, D, Eiris, N, Sahuquillo, A, Mataix, J, Carrascosa, J-M, Cueva, P D L & Salgado-Boquete, L 2026, 'Real-World Effectiveness and Safety of Tildrakizumab in a Large Spanish Multicenter Cohort from Spanish Psoriasis Group (GPS)', Pharmacy, vol. 14, no. 3, 63. https://doi.org/10.3390/pharmacy14030063

Collections

FACULTAD DE MEDICINA